Skeletal muscle properties in a transgenic mouse model for amyotrophic lateral sclerosis: effects of creatine treatment (Q44538961)

3 December 2017

title

Skeletal muscle properties in a transgenic mouse model for amyotrophic lateral sclerosis: effects of creatine treatment (English)

1 reference

amyotrophic lateral sclerosis

3 December 2017

main subject

0 references

author

Wim Derave

1

1 reference

3 December 2017

5

Wim Robberecht

1 reference

3 December 2017

Ludo Van Den Bosch

2

1 reference

3 December 2017

Griet Lemmens

3

1 reference

3 December 2017

Bert O Eijnde

4

1 reference

3 December 2017

Peter Hespel

6

1 reference

3 December 2017

publication date

1 August 2003

1 reference

3 December 2017

published in

Neurobiology of Disease

1 reference

3 December 2017

volume

13

1 reference

3 December 2017

issue

3

1 reference

3 December 2017

page(s)

264-272

1 reference

Creatine increase survival and delays motor symptoms in a transgenic animal model of Huntington's disease

3 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0969-9961%2803%2900041-X

7 January 2021

Increases in cortical glutamate concentrations in transgenic amyotrophic lateral sclerosis mice are attenuated by creatine supplementation.

1 reference

https://api.crossref.org/works/10.1016%2FS0969-9961%2803%2900041-X

7 January 2021

Mitochondria and the pathogenesis of ALS

1 reference

https://api.crossref.org/works/10.1016%2FS0969-9961%2803%2900041-X

7 January 2021

Mitochondrial enzyme activity in amyotrophic lateral sclerosis: implications for the role of mitochondria in neuronal cell death

1 reference

https://api.crossref.org/works/10.1016%2FS0969-9961%2803%2900041-X

7 January 2021

Amyotrophic lateral sclerosis: pathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0969-9961%2803%2900041-X

7 January 2021

Age-dependent penetrance of disease in a transgenic mouse model of familial amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0969-9961%2803%2900041-X

7 January 2021

Creatine supplementation in health and disease: what is the evidence for long-term efficacy?

1 reference

https://api.crossref.org/works/10.1016%2FS0969-9961%2803%2900041-X

7 January 2021

Oral creatine supplementation in Duchenne muscular dystrophy: a clinical and 31P magnetic resonance spectroscopy study

1 reference

https://api.crossref.org/works/10.1016%2FS0969-9961%2803%2900041-X

7 January 2021

Early and selective loss of neuromuscular synapse subtypes with low sprouting competence in motoneuron diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0969-9961%2803%2900041-X

7 January 2021

Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation

1 reference

https://api.crossref.org/works/10.1016%2FS0969-9961%2803%2900041-X

7 January 2021

Elevation of creatine in resting and exercised muscle of normal subjects by creatine supplementation

1 reference

https://api.crossref.org/works/10.1016%2FS0969-9961%2803%2900041-X

7 January 2021

Creatine supplementation: exploring the role of the creatine kinase/phosphocreatine system in human muscle

1 reference

https://api.crossref.org/works/10.1016%2FS0969-9961%2803%2900041-X

7 January 2021

Amyotrophic lateral sclerosis. unfolding the toxicity of the misfolded

1 reference

https://api.crossref.org/works/10.1016%2FS0969-9961%2803%2900041-X

7 January 2021

Central fatigue during isometric exercise in amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0969-9961%2803%2900041-X

7 January 2021

Functional significance of upper and lower motor neuron impairment in amyotrophic lateral sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0969-9961%2803%2900041-X

7 January 2021

Neuroprotective effects of creatine in a transgenic animal model of amyotrophic lateral sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0969-9961%2803%2900041-X

7 January 2021

Massive mitochondrial degeneration in motor neurons triggers the onset of amyotrophic lateral sclerosis in mice expressing a mutant SOD1

1 reference

https://api.crossref.org/works/10.1016%2FS0969-9961%2803%2900041-X

7 January 2021

Skeletal muscle fiber function and rate of disease progression in amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0969-9961%2803%2900041-X

7 January 2021

Selective changes in mitochondria respiratory properties in oxidative or glycolytic muscle fibers isolated from G93AhumanSOD1 transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0969-9961%2803%2900041-X

7 January 2021

The role of excitotoxicity in ALS--what is the evidence?

1 reference

https://api.crossref.org/works/10.1016%2FS0969-9961%2803%2900041-X

7 January 2021

Mutated human SOD1 causes dysfunction of oxidative phosphorylation in mitochondria of transgenic mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0969-9961%2803%2900041-X

7 January 2021

Rats expressing human cytosolic copper-zinc superoxide dismutase transgenes with amyotrophic lateral sclerosis: associated mutations develop motor neuron disease

1 reference

https://api.crossref.org/works/10.1016%2FS0969-9961%2803%2900041-X

7 January 2021

Subcellular distribution of superoxide dismutases (SOD) in rat liver: Cu,Zn-SOD in mitochondria

1 reference

https://api.crossref.org/works/10.1016%2FS0969-9961%2803%2900041-X

7 January 2021

Amyotrophic lateral sclerosis: a proposed mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS0969-9961%2803%2900041-X

7 January 2021

Effect of oral creatine supplementation on human muscle GLUT4 protein content after immobilization

1 reference

https://api.crossref.org/works/10.1016%2FS0969-9961%2803%2900041-X

7 January 2021

Skeletal muscle fatigue and physical endurance of young and old mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0969-9961%2803%2900041-X

7 January 2021

Peripheral mechanisms of fatigue in muscles of normal and dystrophic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0969-9961%2803%2900041-X

7 January 2021

Neuron-specific expression of mutant superoxide dismutase 1 in transgenic mice does not lead to motor impairment.

1 reference

https://api.crossref.org/works/10.1016%2FS0969-9961%2803%2900041-X

7 January 2021

Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0969-9961%2803%2900041-X

7 January 2021

Physiology of fatigue in amyotrophic lateral sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0969-9961%2803%2900041-X

7 January 2021

Electrical and mechanical properties of skeletal muscle underlying increased fatigue in patients with amyotrophic lateral sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0969-9961%2803%2900041-X

7 January 2021

Shortening of muscle relaxation time after creatine loading.

1 reference

https://api.crossref.org/works/10.1016%2FS0969-9961%2803%2900041-X

7 January 2021

Mitochondrial DNA abnormalities in skeletal muscle of patients with sporadic amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0969-9961%2803%2900041-X

7 January 2021

Creatine therapy in myophosphorylase deficiency (McArdle disease): a placebo-controlled crossover trial

1 reference

https://api.crossref.org/works/10.1016%2FS0969-9961%2803%2900041-X

7 January 2021

Intracellular compartmentation, structure and function of creatine kinase isoenzymes in tissues with high and fluctuating energy demands: the 'phosphocreatine circuit' for cellular energy homeostasis

1 reference

https://api.crossref.org/works/10.1016%2FS0969-9961%2803%2900041-X

7 January 2021

10.1016/S0969-9961(03)00041-X

Identifiers

DOI

1 reference

3 December 2017

1 reference